AML |
Acute myeloid leukemia |
BM |
Bone marrow |
CDK1 |
Cyclin-dependent kinase 1 |
CP |
Chronic pancreatitis |
CSC |
Cancer stem cell |
CSP |
Cancer-specific plectin |
CTC |
Circulating tumor cell |
CycB |
Cyclin B |
DAMPs |
Damage-associated molecular patterns |
Dlc1 |
Deleted in liver cancer 1 |
EMT |
Epithelial–mesenchymal transition |
EPLIN |
Epithelial protein lost in neoplasm |
ESCC |
Esophageal squamous cell carcinoma |
EUS-FNA |
Endoscopic ultrasound-guided fine-needle aspiration |
ExAC |
Exosome Aggregation Consortium |
FUS |
Fused in sarcoma |
GEO |
Gene Expression Omnibus |
GNP |
Gold nanoparticle |
GTEx |
Genotype-Tissue Expression |
HR |
Hazard ratio |
HMGB-1 |
High mobility group box protein 1 |
HNSCC |
Head and neck squamous cell carcinoma |
IF |
Intermediate filament |
IHC |
Immunohistochemistry |
IPMNs |
Intraductal papillary mucinous neoplasms |
miR |
microRNA |
MRI |
Magnetic resonance imaging |
MT |
Microtubule |
NP |
Nanoparticle |
OC |
Ovarian Cancer |
OSCC |
Oral squamous cell carcinoma |
PanIN |
Pancreatic intraepithelial neoplasia |
PDAC |
Pancreatic ductal adenocarcinoma |
PKC |
Protein kinase C |
PTP |
Plectin-targeting peptide |
RACK1 |
Receptor of activated protein C kinase 1 |
RON |
Recepteur d’origine nantais |
ROS |
Reactive oxygen species |
SCC |
Squamous cell carcinoma |
SPECT |
Single-photon emission/CT |
TARGET |
Therapeutically Applicable Research to Generate Effective Treatments |
TCGA |
The Cancer Genome Atlas |
TGCT |
Testicular germ cell tumor |
TMA |
Tissue microarray |
TNF |
Tumor necrosis factor |